|
|
???tair.name??? >
???browser.page.title.author???
|
"dai cy"???jsp.browse.items-by-author.description???
Showing items 1-50 of 101 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2024-04-16 |
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients
|
Yeh, ML;Dai, CY;Huang, CF;Huang, SF;Tsai, PC;Hsu, PY;Huang, C;Wei, YJ;Liang, PC;Bair, MJ;Lee, MH;Lin, ZY;Huang, JF;Yu, ML;Chuang, WL |
| 國家衛生研究院 |
2024-03 |
Air pollution as a potential a risk factor for hepatocellular carcinoma in Taiwanese patients after adjusting for chronic viral hepatitis
|
Jang, TY;Ho, CC;Wu, CD;Dai, CY;Chen, PC |
| 國家衛生研究院 |
2024-01-13 |
Comparative evaluation of pediatric fatty liver disease criteria: MASLD, ESPGHAN, NASPGHAN, and NAFLD - identifying the optimal pediatric label
|
Wang, CW;Huang, PC;Dai, CY;Huang, JF;Yu, ML |
| 國家衛生研究院 |
2023-11-10 |
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease
|
Jang, TY;Ho, CC;Liang, PC;Wu, CD;Wei, YJ;Tsai, PC;Hsu, PY;Hsieh, MY;Lin, YH;Hsieh, MH;Wang, CW;Yang, JF;Yeh, ML;Huang, CF;Chuang, WL;Huang, JF;Cheng, YY;Dai, CY;Chen, PC;Yu, ML |
| 國家衛生研究院 |
2023-10-27 |
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs
|
Jang, TY;Liang, PC;Jun, DW;Jung, JH;Toyoda, H;Wang, CW;Yuen, MF;Cheung, KS;Yasuda, S;Kim, SE;Yoon, EL;An, J;Enomoto, M;Kozuka, R;Chuma, M;Nozaki, A;Ishikawa, T;Watanabe, T;Atsukawa, M;Arai, T;Hayama, K;Ishigami, M;Cho, YK;Ogawa, E;Kim, HS;Shim, JJ;Uojima, H;Jeong, SW;Ahn, SB;Takaguchi, K;Senoh, T;Buti, M;Vargas-Accarino, E;Abe, H;Takahashi, H;Inoue, K;Huang, JF;Chuang, WL;Yeh, ML;Dai, CY;Huang, CF;Nguyen, MH;Yu, ML |
| 國家衛生研究院 |
2023-10-27 |
Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
|
Jang, TY;Ho, CC;Wu, CD;Dai, CY;Chen, PC |
| 國家衛生研究院 |
2021-08-12 |
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
|
Huang, JF;Dai, CY;Huang, CF;Tsai, PC;Yeh, ML;Hsu, PY;Huang, SF;Bair, MJ;Hou, NJ;Huang, CI;Liang, PC;Lin, YH;Wang, CW;Hsieh, MY;Chen, SC;Lin, ZY;Yu, ML;Chuang, WL |
| 中山醫學大學 |
2021 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML |
| 國家衛生研究院 |
2020-05 |
Risk of hepatitis C virus infection in injecting and non-injecting drug users receiving opioid substitution therapy
|
Wang, CW;Chuang, HY;Chiang, HC;Huang, PC;Yu, ML;Dai, CY |
| 國家衛生研究院 |
2020-05 |
Risk of hepatitis C virus infection in injecting and noninjecting drug users receiving opioid substitution therapy
|
Wang, CW;Chuang, HY;Chiang, HC;Huang, PC;Yu, ML;Dai, CY |
| 中山醫學大學 |
2020 |
IMPACT OF SOFOSBUVIR-BASED VERSUS NON-SOFOSBUVIR-BASED DIRECT-ACTING ANTIVIRALS ON RENAL FUNCTION IN CHRONIC HEPATITIS C PATIENTS WITH IMPAIRED RENAL FUNCTION- A LARGE COHORT STUDY FROM THE NATIONWIDE REAL-WORLD HCV REGISTRY PROGRAM (TACR)
|
Yu, ML; Chen, CY; Yi, C; Cheng, PN; Tseng, KC; Lo, CC; Hung, CH; Lin, CY; Chen, CH; Peng, CY; Bair, MJ; Hsieh, TY; Lee, PL; Yang, CC; Lin, CL; Mo, LR; Su, WW; Tsai, WL; Chang, CC; Lin, CC; Hsu, SJ; Liu, CH; Huang, YH; Hu, CT; Liu, CJ; Kao, JH; Lee, MH; Chien, RN; Dai, CY; Tsai, PC |
| 國家衛生研究院 |
2019-10 |
Urinary thiodiglycolic acid is associated with increased risk of non-alcoholic fatty liver disease in children living near a petrochemical complex
|
Wang, CW;Chuang, HY;Liao, KW;Yu, ML;Dai, CY;Chang, WT;Tsai, CH;Chiang, HC;Huang, PC |
| 國家衛生研究院 |
2017-01-04 |
The paradoxical effects of different Hepatitis C viral loads on host DNA damage and repair abilities
|
Wang, SC;Lai, KR;Li, CY;Chiang, CS;Yu, GY;Sakamoto, N;Tu, WY;Hsieh, MH;Huang, JF;Chuang, WL;Dai, CY;Yu, ML |
| 高雄醫學大學 |
2015 |
Chronic hepatitis C infection is associated with insulin resistance and lipid profiles
|
戴嘉言;葉明倫;黃釧峰;侯正修;謝明彥;黃志富;林怡伶;林子堯;陳信成;王良彥;張文宇;董宏達; Dai, CY;Yeh, ML;Huang, CF;Hou, CH;Hsieh, MY;Huang, JF;Lin, IL;Lin, ZY;Chen, SC;Wang, LY;Chuang, WL;Yu, ML;Tung HD, . |
| 高雄醫學大學 |
2014 |
Novel quasi-subgenotype D2 of hepatitis B virus identified in Taiwanese aborigines
|
Tran, H;余明隆;戴嘉言;林怡伶;葉明倫;莊萬龍;Abe, K; Tran, H;Yu, ML;Dai, CY;Lin, IL;Yeh, ML;Chuang, WL;Abe, K |
| 高雄醫學大學 |
2014 |
High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients
|
余明隆;戴嘉言;黃釧峰;李佳蓉;葉明倫;葉時孟;郭行道;黃志富;張哲銘;陳鴻鈞;卓夙航;黃尚志;莊萬龍; Yu, ML;Dai, CY;Huang, CF;Lee, JJ;Yeh, ML;Yeh, SM;Kuo, HT;Huang, JF;Chang, JM;Chen, HC;Juo, SH;Hwang, SJ;Chuang, WL;FORMOSA-LIKE, group. |
| 高雄醫學大學 |
2014 |
Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing.
|
鄭貞英;蔡孟峰;蔡蕙如;莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;蔡榮發; Jeng, JE;Tsai, MF;Tsai, HR;Chuang, LY;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Tsai, JF |
| 高雄醫學大學 |
2014 |
Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy.
|
葉明倫;黃釧峰;黃駿逸;劉淑芬;楊華齡;謝明彥;黃志富;戴嘉言;莊萬龍;余明隆; Yeh, ML;Huang, CF;Huang, CI;Liu, SF;Yang, HL;Hsieh, MY;Huang, JF;Dai, CY;Chuang, WL;Yu, ML |
| 高雄醫學大學 |
2014 |
inosine triphosphate pyrophosphatase 基因變異與慢性C型肝炎2/3基因型治療復發危險
|
戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;Yu, ML |
| 高雄醫學大學 |
2014 |
A 24-Week Pegylated Interferon Alpha-2b Versus a 12-Week Pegylated Interferon Alpha-2b Alone or With Ribavirin for Patients With Acute Hepatitis C
|
戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;ML*, Yu |
| 高雄醫學大學 |
2014 |
Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma
|
鄭貞英;蔡孟峰(共同第一);蔡蕙如(共同第一);莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;蔡榮發; Jeng, JE;Tsai, MF;Tsia, HR;Chuang, LY;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Tsai, JF |
| 高雄醫學大學 |
2014 |
Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study
|
鄭貞英;吳慧芳;蔡孟峰;蔡蕙如;莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;蔡榮發; Jeng, JE;Wu, HF;Tsai, MF;Tsai, HR;Chuang, LY;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Tsai, JF |
| 中國醫藥大學 |
2013-03 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced HBeAg seroconversion
|
(Yang HC);(Chen CL);(Shen YC);彭成元(Cheng-Yuan Peng);(Liu CJ);(Tseng TC);(Su TH);(Chuang WL);(Yu ML);(Dai CY);(Liu CH);(Chen PJ);(Chen DS);(Kao JH)* |
| 國家衛生研究院 |
2013-01 |
Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
|
Shiah, HS;Chen, CY;Dai, CY;Hsiao, CF;Lin, YJ;Su, WC;Chang, JY;Whang-Peng, J;Lin, PW;Huang, JD;Chen, LT |
| 高雄醫學大學 |
2013 |
Pegylated interferon and ribavirin: A therapeutic option in patients who fail to respond to telaprevir-based triple therapy?
|
戴嘉言;莊萬龍;余明隆 ; Dai, CY;Chuang, WL;Yu, ML. |
| 高雄醫學大學 |
2013 |
Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapy
|
陳君豪;黃志富;黃釧峰;葉明倫;楊正福;謝明彥;侯乃仁;林子堯;陳信成;謝明裕;王良彥;莊萬龍;戴嘉言;余明隆 ; Chen, CH;Huang, JF;Huang, CF;Yeh, ML;Yang, JF;Hsieh, MY;Hou, NJ;Lin, ZY;Chen, SC;Hsieh, MY;Wang, LY;Chuang, WL;Dai, CY;ML , Yu |
| 高雄醫學大學 |
2012 |
The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy
|
黃志富;余明隆;黃釧峰;卓夙航;戴嘉言;謝明彥;侯乃仁;葉明倫;謝孟軒;楊正福;林子堯;陳信誠;辛鍚章;莊萬龍 ; Huang JF;Yu ML;Huang CF;Juo SH;Dai CY;Hsieh MY;Hou NJ;Yeh ML;Hsieh MH;Yang JF;Lin ZY;Chen SC;Shin SJ;Chuang WL. |
| 高雄醫學大學 |
2012 |
Waist circumference; body mass index; serum uric acid; blood sugar; and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.
|
謝孟軒;林文一;潛詡涵;簡麗合;黃兆寬;楊正福;張寧家;黃釧峰;王肈齡;莊萬龍;余明隆;戴嘉言;何啟功 ; Hsieh, MH;Lin, WY;Chien, HH;Chien, LH;Huang, CK;Yang, JF;Chang, NC;Huang, CF;Wang, CL;Chuang, WL;Yu, ML;Dai, CY;Ho, CK |
| 高雄醫學大學 |
2011 |
Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
|
黃志富;黃釧峰;余明隆;戴嘉言;黃駿逸;葉明倫;謝明裕;楊正福;謝明彥;林子堯;陳信成;莊萬龍 ; Huang JF;Huang CF;Yu ML;Dai CY;Huang CI;Yeh ML;Hsieh MH;Yang JF;Hsieh MY;Lin ZY;Chen SC;Chuang WL |
| 高雄醫學大學 |
2011 |
The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - A multicenter prospective trial.
|
黃志富;余明隆;黃釧峰;丘長富;戴嘉言;黃駿逸;葉明倫;楊正福;謝明彥;侯乃仁;林子堯;陳信成;王良彥;莊萬龍 ; Huang JF;Yu ML;Huang CF;Chiu CF;Dai CY;Huang CI;Yeh ML;Yang JF;Hsieh MY;Hou NJ;Lin ZY;Chen SC;Wang LY;Chuang WL. |
| 高雄醫學大學 |
2011 |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.
|
葉明倫;黃志富;劉俊人;李詮謀;戴嘉言;王景弘;林子堯;盧勝男;胡崇輝;余明隆;高嘉宏;莊萬龍;陳培哲;陳定信 ; Yeh ML;Hung CH;Huang JF;Liu CJ;Lee CM;Dai CY;Wang JH;Lin ZY;Lu SN;Hu TH;Yu ML;Kao JH;Chuang WL;Chen PJ;Chen DS. |
| 高雄醫學大學 |
2011 |
Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
|
楊正福;林雅雲;謝孟軒;蔡秋鴻;劉淑芬;余明隆;戴嘉言;黃志富;林文一;林子堯;陳信成;莊萬龍 ; Yang JF;Lin YY;Hsieh MH;Tsai CH;Liu SF;Yu ML;Dai CY;Huang JF;Lin WY;Lin ZY;Chen SC;Chuang WL. |
| 高雄醫學大學 |
2011 |
Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1
|
陳顧中;謝易仲;眭致遠;王永松;戴嘉言;周玟玟;卓夙航. ; Chen KC;Hsieh IC;Hsi E;Wang YS;Dai CY;Chou WW;Juo SH. |
| 臺北醫學大學 |
2011 |
OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases
|
Chen, KC;Wang, YS;Hu, CY;Chang, WC;Liao, YC;Dai, CY;Juo, SH |
| 高雄醫學大學 |
2010 |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
|
余明隆;李詮謀;莊萬龍;盧勝男;戴嘉言;黃志富;林子堯;胡琮輝;陳建宏;洪肇宏;王景弘;高嘉宏;賴明陽;劉振驊;蘇東弘;廖麗瑛;郭行道;趙有誠;董水義;楊賢馨;陳培哲;劉俊人;陳定信 ; Yu ML;Lee CM;Chuang WL;Lu SN;Dai CY;Huang JF;Lin ZY;Hu TH;Chen CH;Hung CH;Wang JH;Chen CL;Kao JH;Lai MY;Liu CH;Su TH;Wu SS;Liao LY;Kuo HT;Chao YC;Tung SY;Yang SS;Chen PJ;Liu CJ;Chen DS. |
| 高雄醫學大學 |
2010 |
C型肝炎病毒基因型第2/3型病毒病患以長效干擾素/雷巴威林縮短療程合併治療:雷巴威林起始劑量之重要角色
|
戴嘉言;黃釧峰;黃志富;莊萬龍;余明隆 ; Dai CY;Huang CF;Huang JF;Chuang WL;Yu ML |
| 高雄醫學大學 |
2010 |
Insulin resistance; viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.
|
戴嘉言;黃志富;謝明彥;莊萬龍;余明隆 ; Dai CY;Huang JF;Hsieh MY;Chuang WL;Yu ML |
| 高雄醫學大學 |
2010 |
慢性C型肝炎病患接受治療:我們可期待或做更多嗎?
|
戴嘉言 ; Dai CY |
| 高雄醫學大學 |
2009 |
Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms; substance use habits; and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.
|
鄭貞英;蔡蕙如;莊麗月;蔡榮發;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;張建國 ; Jeng JE;Tsai HR;Chuang LY;Tsai JF;Lin ZY;Hsieh MY;Chen SC;Chuang WL;Wang LY;Yu ML;Dai CY;Chang JG. |
| 高雄醫學大學 |
2009 |
慢性C型肝炎患者接受長效型干擾素合併治療引起之中性白血球低下與細菌感染之關係
|
楊正福;謝明彥;侯乃仁;戴嘉言;黃志富;林子堯;陳信成;謝明裕;王良彥;莊萬龍;余明隆 ; Yang JF;Hsieh MY;Hou NJ;Dai CY;Huang JF;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chuang WL;Yu ML. |
| 高雄醫學大學 |
2009 |
B型肝炎e 抗原陰性病患具持續正常肝指數與病毒量血症高於 2000 IU/mL
|
戴嘉言;莊萬龍;黃志富;余明隆 ; Dai CY;Chuang WL;Huang JF;Yu ML |
| 高雄醫學大學 |
2009 |
Insight into Alcohol Consumption-Related Problems and Its Correlates Among Taiwanese Alcoholic Hepatogastroenterological Clinic Patients.
|
顏正芳;戴嘉言;侯乃仁;余明隆 ; Yen CF;Dai CY;Hou NJ;Hsiao RC;Yu ML |
| 高雄醫學大學 |
2009 |
胰島素阻抗可預測慢性C型肝炎病毒以長效干擾素合併ribavirin合併治療之反應
|
戴嘉言;黃志富;謝明彥;侯乃仁;林子堯;陳信成;謝明裕;王良彥;張文宇;莊萬龍;余明隆 ; Dai CY;Huang JF;Hsieh MY;Hou NJ;Lin ZY;Chen SC;Hsieh MY;Wang LY;Chang WY;Chuang WL;Yu ML |
| 高雄醫學大學 |
2009 |
C型肝炎病毒長效干擾素合併ribavirin治療病毒反應之病毒與宿主因子
|
戴嘉言;莊萬龍;黃志富;謝明彥;余明隆 ; Dai CY;Chuang WL;Huang JF;Hsieh MY;Yu ML |
| 高雄醫學大學 |
2009 |
ribavirin早期劑量與C型肝炎病毒基因型第一型病毒合併治療反應之角色
|
戴嘉言;黃釧峰;莊萬龍;黃志富;余明隆 ; Dai CY;Huang CF;Chuang WL;Huang JF;Yu ML |
| 高雄醫學大學 |
2009 |
雷巴威林起始劑量與C型肝炎病毒基因型第1b亞型病毒以長效干擾素/雷巴威林合併治療反應之重要角色
|
戴嘉言;黃釧峰;莊萬龍;黃志富;余明隆 ; Dai CY;Huang CF;Chuang WL;Huang JF;Yu ML |
| 高雄醫學大學 |
2009 |
C型肝炎病毒血症型與血脂值:流行病學研究線索
|
戴嘉言;莊萬龍;何啟功; , 余明隆; Dai, CY;Chuang, WL;Ho, CK; , Yu ML |
| 高雄醫學大學 |
2009 |
Independent;additive interactive effects among tumor necrosis factor-alpha polymorphisms;substance use habits;and chronic hepatitis B;hepatitis C virus infection on risk for hepatocellular carcinoma.
|
鄭貞英;蔡蕙如;莊麗月;蔡榮發;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;張建國 ; Jeng, JE;Tsai, HR;Chuang, LY;Tsai, JF;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Chang JG, . |
| 臺北醫學大學 |
2008 |
Fuzzy Pain Demand Index from an i-Pain System for Assessment of Postoperative Pain via Patient-Controlled Analgesia Using Different Amounts and Combination Drugs
|
溫永銳; Shieh JS; Dai CY; Wen YR; Lin TY; Sun WZ; |
| 高雄醫學大學 |
2008 |
一種實時間反轉錄多聚酶鏈反應試劑應用於基因型第一與第二型C型肝炎病毒定量測定之表現特徵
|
黃志富;戴嘉言;林雅雲;余明隆;劉淑芬;林怡伶;謝明彥;李立柏;林子堯;陳信成;謝明裕;張文宇;莊萬龍 ; Huang JF;Dai CY;Lin YY;Yu ML;Liu SF;Lin IL;Hsieh MY;Lee LP;Lin ZY;Chen SC;Hsieh MY;Chang WY;Chuang WL |
Showing items 1-50 of 101 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
|
